Clinical Report: A Comprehensive Prediction Model for Assessing Futile Reperfusion
Overview
This study presents a prediction model for futile reperfusion in acute ischemic stroke patients following endovascular thrombectomy. The model integrates clinical, imaging, and laboratory markers, demonstrating good discriminative ability and providing a nomogram for individualized risk assessment.
Background
Acute ischemic stroke (AIS) is a leading cause of disability and mortality, with endovascular thrombectomy (EVT) being the standard treatment for large vessel occlusion (LVO). Despite high recanalization rates, many patients experience futile reperfusion, leading to poor outcomes and significant healthcare burdens. Understanding predictors of futile reperfusion is crucial for optimizing treatment strategies and improving patient prognostication.
Data Highlights
Variable
Importance
NIHSS score
Key predictor
CTA-SI ASPECTS
Key predictor
Time from onset to reperfusion
Key predictor
Collateral circulation scores
Key predictor
C-reactive protein
Key predictor
Glucose
Key predictor
WBC count
Key predictor
Neutrophil count
Key predictor
Monocyte count
Key predictor
Key Findings
The final prediction model included nine variables associated with futile reperfusion.
The model achieved a pooled test AUC of 0.795, indicating good discriminative ability.
At the optimal threshold, the model demonstrated a specificity of 0.822 and an accuracy of 0.761.
A nomogram was developed to facilitate individualized risk prediction for patients.
Futile reperfusion is defined as a modified Rankin Scale score of 3–6 at 90 days post-EVT.
Clinical Implications
The developed prediction model can assist clinicians in identifying patients at risk for futile reperfusion after EVT, enabling more informed treatment decisions. By utilizing the nomogram, healthcare providers can tailor interventions based on individual risk profiles, potentially improving patient outcomes.
Conclusion
This study provides a robust multidimensional model for predicting futile reperfusion in AIS patients undergoing EVT. The integration of clinical, imaging, and laboratory markers enhances prognostic accuracy and supports personalized treatment approaches.
